Genomics Bioscience & Technology Co

Genomics Bioscience & Technology Co EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Genomics Bioscience & Technology Co (4195.TWO) as of Oct 9, 2026 is -24.09. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was -18.95 — a change of 27.11% (lower).

EV/OCF

-24.09

YoY

27.11%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Genomics Bioscience & Technology Co is 2025 -24.09 . EV/OCF (Enterprise Value to Operating Cash Flow) of Genomics Bioscience & Technology Co was 2024 -18.95 . It decreases by 27.11% lower compared to the previous year.

The Genomics Bioscience & Technology Co EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2018
25.94 TWD
Jan 1, 2019
18.12 TWD
Jan 1, 2020
-70.36 TWD
Jan 1, 2021
-63.27 TWD
Jan 1, 2022
-79.95 TWD
Jan 1, 2023
-18.83 TWD
Jan 1, 2024
-18.95 TWD
Jan 1, 2025
-24.09 TWD
The Genomics Bioscience & Technology Co EV/OCF history
YEAREV/OCFYoY
-24.09+27.11%
-18.95+0.66%
-18.83-76.45%
-79.95+26.37%
-63.27-10.08%
-70.36-488.20%
18.12-30.13%
25.94-159.46%
-43.62+40.48%
-31.05-301.76%
15.39-184.08%
-18.30—
Access this data via the Eulerpool API
Get Free API Key

Genomics Bioscience & Technology Co Stock analysis

What does Genomics Bioscience & Technology Co do? Genomics Bioscience & Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomics Bioscience & Technology Co stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Genomics Bioscience & Technology Co is -24.09 in 2025.

EV/OCF (Enterprise Value to Operating Cash Flow) of Genomics Bioscience & Technology Co changed from -18.95 to -24.09, representing a 27.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Genomics Bioscience & Technology Co since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Genomics Bioscience & Technology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Genomics Bioscience & Technology Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Genomics Bioscience & Technology Co